Parameter
| Biomarker | Adiponectin | Full name | Adiponectin | Molecular Type | Proteins (adipokines) |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | 30 kDa | Core Functional Dimensions | Susceptibility, prognosis |
| Disease | hypertension | Disease Subtypes | / | ||
| Organ | Adipose tissue | Test Sample / Technology Platform | Serum/plasma (ELISA, mass spectrometry) | ||
| Pathobiological Mechanisms | It has anti-inflammatory and anti-atherosclerotic effects, and reduced levels can exacerbate vascular endothelial dysfunction and increase blood pressure | ||||
| Clinical Availability Status | Study validation: negative correlation with hypertension, used to assess the risk of metabolism-related hypertension | ||||
| Notes and Dynamics | Adiponectin levels are significantly decreased in obese and insulin resistant patients, and supplementation of adiponectin analogues can improve vascular function in experimental hypertension | ||||